• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Belgium·Industrials·FLOB.BR
Share

Floridienne S.A. Stocks

€ 61Last Updated 12.06.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

€ 655.06M

€ 61
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Floridienne S.A., established in Waterloo, Belgium in 1898, is an international company that operates through its various subsidiaries across three core sectors: chemicals, gourmet food, and life sciences. Its Chemicals division specializes in the production of plastic additives, including stabilizers for PVC and fire-retardant agents for plastics. This division also handles the recycling of nickel/cadmium, nickel-metal hybrid, and lithium-ion rechargeable batteries, and supplies zinc salts for galvanization. Furthermore, it is responsible for developing and manufacturing calcium/zinc-based and organic stabilizers. The Gourmet Food division is dedicated to creating and distributing a diverse range of premium and celebratory food items. These offerings span from appetizers and prepared dishes like snails, scallops, stuffed shellfish, and smoked salmon, to seafood salads, flaky pastry bites, and various ethnic meals. The product line also includes an assortment of cold and warm sauces, vinegars, condiments, jams, and spreads. A unique focus of this division is the provision of specialized food products designed for individuals experiencing swallowing difficulties. Finally, the Life Sciences division develops and commercializes natural technologies and products tailored for the agricultural, agri-foodstuff, healthcare, parapharmaceutical, and cosmetics industries. It offers services such as plant proteases and integrated pest management solutions. Additionally, this division allocates resources to researching and implementing solutions, particularly in the realm of chemical communication involving taste and olfactory receptors in mammals.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of FLOB.BR is 71 and suggests 22% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

13.06.2026 03:02

Microsoft is considering spinning off Xbox into a separate company - The Information

13.06.2026 01:40

Hope for peace with Iran and SpaceX lifted spirits: stocks rose for second straight day

13.06.2026 01:05

SpaceX shares rose in value by 19% on the first day of trading. Is it worth buying them?

13.06.2026 01:04

SpaceX shares slowed before closing in first trading since record IPO

13.06.2026 00:44

Retail investors bought $15 billion worth of SpaceX stock. Demand was at least 6 times that amount

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026